News | February 10, 2014

Kuster's Breast Density and Mammography Report Act to promote breast cancer detection, prevention

Breast Density and Mammography Reporting Act Kuster Women's Health

February 10, 2014 — Congresswoman Annie Kuster (NH-02) met Jan. 21 with executives from Gamma Medica to discuss the Breast Density and Mammography Reporting Act. Kuster recently cosponsored the bill in an effort to promote better breast cancer detection and prevention, and to help provide women with the tools to make informed health decisions.
 
“Thousands of women in New Hampshire and across the country are being diagnosed with breast cancer each year. It’s absolutely essential they have every tool available to battle this terrible disease,” Kuster said. “That’s what the Breast Density and Mammography Reporting Act is all about. It will help to make sure women, especially those at greater risk for breast cancer, can detect it early and return to good health.”
 
First introduced by Congresswoman Rosa DeLauro, the bill ensures that relative breast density is included in the information provided to women and health care providers following a mammogram. Studies have shown that women with dense breast tissue are at least four times more likely to develop breast cancer, and they are also more likely to have an inaccurate mammogram reading.
 
Gamma Medica develops, markets and services molecular breast imaging systems to help radiologists detect early stage cancers. The company utilizes molecular breast imaging, a secondary diagnostic tool that enables and improves assessments, especially for women with dense breast tissue.
 
In 2013, an estimated 1,180 Granite State women were projected to be newly diagnosed with breast cancer, according to the New Hampshire Breast Cancer Coalition. An estimated 170 were projected to die of the disease.
 
Earlier this year, Kuster called on the U.S. Department of Health and Human Services (HHS) to cover certain medications that help prevent breast cancer under the Affordable Care Act. HHS issued a ruling that women who are at a higher risk for breast cancer will have access to certain categories of preventative drugs without any out-of-pocket costs.
 
For more information: www.gammamedica.com

Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now